Clinical assessment of a low-dose oestrogen, low-dose progestogen combined oral contraceptive.
Curr Med Res Opin
; 2(2): 101-8, 1974.
Article
em En
| MEDLINE
| ID: mdl-4828625
ABSTRACT
PIP The efficacy, safety, and patient acceptance of an oral contraceptive containing 150 mcg d-norgestrel and 30 mcg ethinyl estradiol (150/30) were studied in 99 women who completed 754 cycles of medication between late 1971 and October 1973. 1 pregnancy occurred giving a pregnancy rate of 1.6 per 100 woman-years. This woman's previous history indicated unreliability in pill taking. The mean pretreatment length of menses was 4.9 days and during treatment, 4 days. Although intermenstrual bleeding and amenorrhea were noted in early cycles, there was a decrease in the usual incidence of headaches, nausea, vomiting, and depression. Results of the study and patients' acceptance suggest that the 150/30 combination may be used as the oral contraceptive of first choice.^ieng
Palavras-chave
Amenorrhea; Bleeding; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Diseases; Ethinyl Estradiol; Family Planning; Menstruation Disorders; Metrorrhagia; Oral Contraceptives, Combined; Oral Contraceptives, Low-dose; Oral Contraceptives--side effects; Research Methodology; Signs And Symptoms
Buscar no Google
Temas:
ECOS
/
Aspectos_gerais
Bases de dados:
MEDLINE
Assunto principal:
Anticoncepcionais Orais
/
Etinilestradiol
/
Norgestrel
Limite:
Adult
/
Female
/
Humans
/
Pregnancy
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Curr Med Res Opin
Ano de publicação:
1974
Tipo de documento:
Article